Skip to content

Scholar Rock SRRK Operating lease right-of-use asset amortization

Operating lease right-of-use asset amortization at other companies

PTC Therapeutics logo
PTC TherapeuticsPTCT
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
BridgeBio Pharma logo
BridgeBio PharmaBBIO
Roivant Sciences logo
Roivant SciencesROIV
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD

Other financials

Income statement

See full
Revenue-
Operating income-$102.0M-32.3%
Net income-$105.5M-41.2%
EPS (diluted)-$0.83-23.9%

Balance sheet

See full
Cash & equivalents$430.5M+212%
Total debt$205.7M+226%
Total equity$276.0M-11.6%
Total assets$535.3M+31.3%

Cash flow

See full
Operating cash flow-$82.1M-4.4%
CapEx$68.0K-74.9%
Free cash flow-$82.2M-4.1%

Valuation

See full
Market cap$5.67B+85.5%
Enterprise value$5.45B+82.6%
P/S170.9×

Profitability

See full
Operating margin-231.8%
Net margin-236.9%
FCF margin-309.1%

Returns & leverage

See full
Return on equity-138.9%+60.1pp
Debt / equity0.7×+0.5×
Current ratio8.6×-1.6×

Where this comes from

Reported directly by Scholar Rock in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense.

The official record: Scholar Rock’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Scholar Rock's operating lease right-of-use asset amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Scholar Rock's operating lease right-of-use asset amortization?
Scholar Rock (SRRK) reported operating lease right-of-use asset amortization of $1.54M in Q1 2026.
How has Scholar Rock's operating lease right-of-use asset amortization changed year-over-year?
Scholar Rock's operating lease right-of-use asset amortization increased by 24.1% year-over-year, from $1.24M to $1.54M.
What is the long-term trend for Scholar Rock's operating lease right-of-use asset amortization?
Over 4 years (2021 to 2025), Scholar Rock's operating lease right-of-use asset amortization has grown at a -4.8% compound annual growth rate (CAGR), from $6.4M to $5.26M.